TrialCancer immunology, immunotherapy : CII2019

Phase II clinical trial of adoptive cell therapy for patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and low-dose interleukin-2.

Linh T Nguyen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.